Conference Coverage

VIDEO: Move beyond BMI to see obesity as a disease


 

REPORTING FROM AACE 2018

The five medications approved for chronic management of obesity all have been shown to be safe and effective in clinical trials. But they have different mechanisms of action, different side effect profiles, and different warnings and precautions, Dr. Garvey noted.

Understanding the pharmacology of all five drugs is important to help a specific patient achieve the best outcomes.

“There’s no drug that can be recommended, in a hierarchical sense, as being better than any others across the board in all patients,” Dr. Garvey explained. “We really need to individualize therapy based on their side effect profile and their types of complications that present with the patient.”

Recommended Reading

Family’s psychosocial problems complicate pediatric obesity
MDedge Psychiatry
Weight loss procedure is linked to subsequent substance misuse
MDedge Psychiatry
Prepregnancy overweight boosts risk of depressive symptoms in pregnancy
MDedge Psychiatry
Unhealthy eating habits might precede depressive symptoms
MDedge Psychiatry
Toddlers’ neurodevelopmental deficits linked with maternal diabetes
MDedge Psychiatry
What works and what doesn’t in treating binge eating
MDedge Psychiatry
Fat shaming interferes with patients’ medical care, experts say
MDedge Psychiatry
MDedge Daily News: Why low-calorie sucralose may fuel weight gain
MDedge Psychiatry
Life and health are not even across the U.S.
MDedge Psychiatry
MDedge Daily News: Physician burnout needs more than yoga
MDedge Psychiatry